Iobenguane Sulfate I 123 vs Ipilimumab
Iobenguane Sulfate I 123 vs Ipilimumab: Overview
This comparison examines the pharmacological differences between Iobenguane Sulfate I 123 and Ipilimumab.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Iobenguane Sulfate I 123 β Small molecule; Ipilimumab β Antibody.